Interview: Michel van Agthoven – Chair of the Pharmaceutical Committee…
Michel van Agthoven outlines the role played by the Pharmaceutical Committee of the American Chamber in…
Company description
The American Chamber of Commerce in the Netherlands (AmCham) is a non-profit, non-governmental, non-political, voluntary organization of companies and individuals who invest in and trade between the United States of America and the Netherlands. The Netherlands is one of the most important destinations for US direct investment in Europe and a major hub of American professionals living and working abroad.
Products and services
American and Chamber member companies employ over 1.3 million people in the Netherlands. Of these, minority and majority owned American companies directly employ over 210,000 people and are the source of almost 5 percent of the country’s GNP. On a historical-cost basis the total US direct investment position in the Netherlands in 2008 totaled over $440 billion (source: US Dept. of Commerce, Bureau of Economic Analysis). Total assets of US non-bank foreign affiliates in the Netherlands were estimated to total over $1.18 trillion in 2007. Over the past decade alone, US direct investment flows have totaled over $250 billion. American business has had good reason to come to the Netherlands in the past and the Chamber works to ensure they have good reason to stay in the future.
Many Dutch Chamber members are significant investors in the United States. Well over $250 billion of investment has flowed from the Netherlands to the United States – making the Netherlands the fourth largest foreign investor in the US. The common denominator shared by all our members is a belief in the importance of two-way trade and investment between the Netherlands and the United States as an essential basis for creating mutual economic welfare.
Established in 1961 and now in its fifth decade of service to the US business community, the American Chamber of Commerce in the Netherlands seeks to further the development of commerce between the United States of America and the Netherlands. AmCham Netherlands encourages and facilitates the transaction of business between both countries and promotes the interests of its members in matters of trade and investment.
Contact
American Chamber of Commerce in the Netherlands
P.O. Box 15783
1001 NG Amsterdam
Tel: +31 (0)20 7951840
Fax: +31 (0)20 7951850
Email: office@amcham.nl
Michel van Agthoven outlines the role played by the Pharmaceutical Committee of the American Chamber in…
How do you operate in terms of the stakeholder management, with all of your associate members? Do you tend to…
Given the peculiarities of the pharmaceutical industry in the Netherlands, such as the highest generics penetration…
The European Medicines Agency (EMA), the EU body responsible for the evaluation of medicinal products for use…
Leo de Haan of Aurobindo discusses how to maintain a profitable business in times of rock-bottom generics prices in…
Despite lacking a national champion to bolster its innovative eco-system since the 2007 acquisition of Organon by…
The Netherlands is clearly a fertile environment for its 2,200 life science and medtech companies. However, the…
Sobi is a leading integrated biopharmaceutical company dedicated to developing innovative therapies and services to…
Paul Korte, General Manager for Janssen in the Netherlands, highlights the strategic move and leadership position…
In an exclusive interview, the Vice President of Philips Research explains the key to continuous evolution,…
Healthcare is moving towards an increased level of personalization and active participation of the patient in the…
Teva Benelux and Nordics’ GM lifts the lid on how the company has grown to become the market leader in the…
Takeda’s goal is to become a trusted and reliable partner in the healthcare system by better understanding…
In many aspects, 2016 truly marks the dawn of a new era for Toshiba Medical Systems. Lo Wuite (LW), General Manager…
DHL Supply Chain Benelux understands the challenges life sciences companies face and has developed solutions to…